Exonhit S.A. (ALEHT) - Product Pipeline Analysis

Exonhit S.A. (ALEHT) - Product Pipeline Analysis

Summary

ExonHit is a medical diagnostic company. It focuses on development and marketing of genomic profiling technology, diagnostic solutions and drugs. The company has developed a genomic profiling technology known as Differential Analysis of Transcripts with Alternative Splicing (DATAS) to identify genes that may contribute for the development of disease. The company specializes in analysis of alternative RNA splicing, a process where single gene attracts many proteins. ExonHit has also developed Splice Arrays micro arrays which are able to detect essential alternative splicing events connected with diseases. Recently, ExonHit Therapeutics entered in a liquidity agreement with Natixis Securities.

Key business strategy includes increased focus on making alliance and internal development programs with others in the healthcare industry. As a part of the strategy, the company has agreements with Allergan and Institut Gustave Roussy. ExonHit is headquartered in Paris, France. On March 5, 2012 the company received a grant of €418,000 from the European Union through its participation in 7th Framework Program for Research and Technological Development to finance research and development projects.

This report is a source for data, analysis and actionable intelligence on the Exonhit S.A. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities by identifying market players with the most innovative pipeline.
- Develop market-entry and market expansion strategies.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
- Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize. SHOW LESS READ MORE >

List of Tables
List of Figures
Key Facts
Exonhit S.A. - Major Products and Services
Exonhit S.A. Pipeline Products by Equipment Type
Exonhit S.A. Pipeline Products by Development Stage
Exonhit S.A. Pipeline Products by Therapy Area
Exonhit S.A. Pipeline Products by Milestone Summary
AclarusDx
AclarusDx Product Status
AclarusDx Product Description
AclarusDx Product Milestone
AclarusDx Product Patent Details
EHT Dx 13
EHT Dx 13 Product Status
EHT Dx 13 Product Description
EHT Dx 13 Product Patent Details
EHT Dx14
EHT Dx14 Product Status
EHT Dx14 Product Description
EHT Dx14 Product Milestone
Exonhit S.A. - Key Competitors
Exonhit S.A. - Key Employees
Exonhit S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Exonhit S.A., Recent Developments
Jun 05, 2012: Exonhit Receives €1.93m From OSEO For Personalized Medicine TEDAC Project In Cancer
Mar 22, 2012: Exonhit Reports Revenue Of €5m In 2011
Mar 05, 2012: Exonhit Receives €418,000 EU Grant Through Responsify Consortium
Nov 02, 2011: ExonHit Extends Strategic Collaboration With Allergan Sales
Sep 07, 2011: Exonhit Appoints Isabelle Barber To Management Board
May 18, 2011: ExonHit Therapeutics Changes Name To Exonhit
Mar 15, 2011: ExonHit Reports Net Loss Of €7.74m For 2010
Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
Exonhit S.A., Key Facts
Exonhit S.A. Key Pipeline Products by Equipment Type
Exonhit S.A. Key Pipeline Products by Therapy Area
Exonhit S.A. Key Pipeline Products by Development Stage
Exonhit S.A., Key Facts
Exonhit S.A., Major Products and Services
Exonhit S.A. Number of Pipeline Products by Equipment Type
Exonhit S.A. Pipeline Products by Equipment Type
Exonhit S.A. Number of Pipeline Products by Development Stage
Exonhit S.A. Pipeline Products by Development Stage
Exonhit S.A. Number of Pipeline Products by Therapy Area
Exonhit S.A. Pipeline Products by Therapy Area
Exonhit S.A. Number of Pipeline Products By Milestone Summary
Exonhit S.A. Pipeline Products by Milestone Summary
AclarusDx - Product Status
AclarusDx - Product Description
AclarusDx - Product Milestone
AclarusDx - Patent Details1
AclarusDx - Patent Details2
AclarusDx - Patent Details3
AclarusDx - Patent Details4
AclarusDx - Patent Details5
AclarusDx - Patent Details6
AclarusDx - Patent Details7
AclarusDx - Patent Details8
AclarusDx - Patent Details9
AclarusDx - Patent Details10
AclarusDx - Patent Details11
AclarusDx - Patent Details12
AclarusDx - Patent Details13
AclarusDx - Patent Details14
AclarusDx - Patent Details15
AclarusDx - Patent Details16
AclarusDx - Patent Details17
AclarusDx - Patent Details18
AclarusDx - Patent Details19
AclarusDx - Patent Details20
EHT Dx 13 - Product Status
EHT Dx 13 - Product Description
EHT Dx 13 - Patent Details1
EHT Dx 13 - Patent Details2
EHT Dx 13 - Patent Details3
EHT Dx 13 - Patent Details4
EHT Dx 13 - Patent Details5
EHT Dx 13 - Patent Details6
EHT Dx 13 - Patent Details7
EHT Dx 13 - Patent Details8
EHT Dx 13 - Patent Details9
EHT Dx 13 - Patent Details10
EHT Dx 13 - Patent Details11
EHT Dx 13 - Patent Details12
EHT Dx 13 - Patent Details13
EHT Dx 13 - Patent Details14
EHT Dx 13 - Patent Details15
EHT Dx 13 - Patent Details16
EHT Dx 13 - Patent Details17
EHT Dx 13 - Patent Details18
EHT Dx 13 - Patent Details19
EHT Dx 13 - Patent Details20
EHT Dx14 - Product Status
EHT Dx14 - Product Description
EHT Dx14 - Product Milestone
Exonhit S.A., Key Employees
Exonhit S.A., Subsidiaries

List of Figures
Exonhit S.A. Pipeline Products by Equipment Type
Exonhit S.A. Pipeline Products by Development Stage
Exonhit S.A. Pipeline Products by Therapy Area
Exonhit S.A. Pipeline Products by Milestone Summary

genOway SA
Iverson Genetic Diagnostics, Inc.
Trace Genetics, Inc.
Aniara Corporation
Full Moon BioSystems, Inc.